Systematic Review and Meta-Analysis of Randomized Controlled Trials of Fuke Qianjin Tablet

Table 4

Meta-analysis results of primary outcomes.

Indication	Type of intervention		Number of studies included	Cases	Heterogeneity test		Effect model	Results of the meta-analysis
	Experimental group	Control group			I^2			OR (95% CI)	z
Acute PID	Total effective rate		23		0.0%	0.999	F	5.57 (4.09, 7.58)	10.90	0.001
	FKQJP + control group	Penicillin	6	549	0.0%	0.711	F	5.77 (3.17, 10.49)	5.74	0.001
	FKQJP + control group	Penicillin + metronidazole	7	801	0.0%	0.887	F	7.80 (4.00, 15.18)	6.04	0.001
	FKQJP + control group	Quinolones	2	206	0.0%	0.584	F	3.99 (1.81, 8.77)	3.44	0.001
	FKQJP + control group	Quinolones + nitroimidazole	2	140	0.0%	0.773	F	7.23 (1.78, 29.28)	2.77	0.006
	FKQJP + control group	Roxithromycin	2	180	0.0%	0.809	F	4.59 (1.63, 12.96)	2.88	0.004
	FKQJP + control group	Metronidazole	2	132	0.0%	0.330	F	2.96 (1.07, 8.22)	2.08	0.037
	FKQJP + moxifloxacin	Ceftriaxone + tinidazole	2	220	0.0%	0.829	F	5.90 (2.45, 14.20)	3.96	0.001
	Incidence of adverse reaction	10	10	958	0.0%	0.989	F	0.71 (0.45, 1.10)	1.55	0.121
Chronic PID	Total effective rate		69	8478	0.0%	0.999	F	4.70 (4.07, 5.42)	21.21	0.001
	FKQJP	β-Lactam + nitroimidazole	2	284	0.0%	0.735	F	2.55 (1.52, 4.28)	3.53	0.001
	FKQJP + control group	β-Lactam	7	626	0.0%	0.939	F	3.88 (2.34, 6.45)	5.24	0.001
	FKQJP + control group	β-Lactam + nitroimidazole	7	700	0.0%	0.918	F	6.27 (3.46, 11.37)	6.04	0.001
	FKQJP+β-lactam + nitroimidazole	FKQJP	2	250	0.0%	0.579	F	7.80 (3.29, 18.50)	4.66	0.001
	FKQJP + control group	Macrolide	15	1905	0.0%	0.869	F	3.54 (2.67, 4.68)	8.81	0.001
	FKQJP + control group	Quinolone	8	892	0.0%	0.925	F	5.54 (3.61, 8.52)	7.82	0.001
	FKQJP + control group	Quinolone + nitroimidazole	30	3821	0.0%	1.000	F	5.67 (4.49, 7.16)	14.56	0.001
	Incidence of adverse reaction		30	3082	0.0%	0.708	F	0.60 (0.46, 0.80)	3.55	0.001
Endometritis	Total effective rate		30	3521	0.0%	0.998	F	5.09 (4.03, 6.43)	13.63	0.001
	FKQJP + control group	Antibiotics	4	680	0.0%	0.979	F	9.01 (4.23, 19.21)	5.69	0.001
	FKQJP + antibiotics	Antibiotics + progesterone	12	1122	0.0%	0.969	F	4.84 (3.25, 7.21)	7.77	0.001
	FKQJP + control group	Antibiotics + progesterone	11	1279	0.0%	0.959	F	4.40 (3.03, 6.39)	7.78	0.001
	FKQJP + control group	Antibiotics + progesterone + vaginal douche	3	440	0.0%	0.758	F	5.25 (2.92, 9.44)	5.54	0.001

FKQJP, Fuke Qianjin tablet; R, random-effect model; F, fix-effect model.